ELISPOT for detecting antibody-secreting cells in response to infections and vaccination

APMIS

Volumn 104, Issue 6, 1996, Pages 401-410

  Arvilommi, H ^a  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

Author keywords

Antibody secreting cells; ELISPOT; Enzyme linked immunospot assay; Infection; Vaccine immunogenicity

Indexed keywords

BACTERIAL VACCINE; CHOLERA VACCINE; ESCHERICHIA COLI VACCINE; HEPATITIS B VACCINE; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; INFLUENZA VACCINE; MALARIA VACCINE; ROTAVIRUS VACCINE; SHIGELLA VACCINE;

ANTIBODY PRODUCTION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSPOT ASSAY; HUMAN; HUMAN CELL; INFECTION; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; REVIEW; TECHNIQUE; VACCINATION;

EID: 0029788401     PISSN: 09034641     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1699-0463.1996.tb00734.x     Document Type: Review

References (70)

1. Aaltonen, T. M., Jokinen, E. I. & Valtonen, E. T.: Antibody synthesis in roach (Rutilus rutilus); analysis of antibody secreting cells in lymphoid organs with ELISPOT-assay. Fish Shellfish Immunol. 4: 129-140, 1994.
2. Barington, T., Heilmann, C. & Andersen, V.: Quantitation of antibody-secreting cells in the blood after vaccination with Haemophilus influenzae type b conjugate vaccine [published erratum appears in Scand. J. Immunol. 32: 59, 1990]. Scand. J. Immunol. 31: 515-522, 1990.
3. Barington, T., Juul, L., Gyhrs, A. & Heilmann, C.: Heavy-chain isotype patterns of human antibody-secreting cells induced by Haemophilus influenzae type b conjugate vaccines in relation to age and preimmunity. Infect. Immun. 62: 3066-3074, 1994.
4. Barington, T., Kristensen, K., Henrichsen, J. & Heilmann, C.: Influence of prevaccination immunity on the human B-lymphocyte response to a Haemophilus Influenzae type b conjugate vaccine. Infect. Immun. 59: 1057-1064, 1991.
5. Bianchi, A. T., Scholten, J. W., Jongenelen, I. M. & Koch, G.: The use of monoclonal antibodies in an enzyme immunospot assay to detect isotype-specific antibody-secreting cells in pigs and chickens. Vet. Immunol. Immunopathol. 24: 125-134, 1990.
6. Carson, P. J., Schut, R. L., Simpson, M. L., O'Brien, J. & Janoff, E. N.: Antibody class and subclass responses to pneumococcal polysaccharides following immunization of human immunodeficiency virus-infected patients. J. Infect. Dis. 172: 340-345, 1995.
7. Cox, R. J., Brokstad, K. A., Zuckerman, M. A., Wood, J. M., Haaheim, L. R. & Oxford, J. S.: An early humoral immune response in peripheral blood following parenteral inactivated influenza vaccination. Vaccine 12: 993-999, 1994.
8. Cupps, T. R., Goldsmith, P. K., Volkman, D. J., Gerin, J. L., Purcell, R. H. & Fauci, A. S.: Activation of human peripheral blood B cells following immunization with hepatitis B surface antigen vaccine. Cell Immunol. 86: 145-154, 1984.
9. Czerkinsky, C., Andersson, G., Ekre, H. P., Nilsson, L. A., Klareskog, L. & Ouchterlony, O.: Reverse ELISPOT assay for clonal analysis of cytokine production. I. Enumeration of gamma-interferon-secreting cells. J. Immunol. Methods 110: 29-36, 1988.
10. Czerkinsky, C., Prince, S. J., Michalek, S. M., Jackson, S., Russell, M. W., Moldoveanu, Z., McGhee, J. R. & Mestecky, J.: IgA antibody-producing cells in peripheral blood after antigen ingestion: evidence for a common mucosal immune system in humans. Proc. Natl. Acad. Sci. USA 84: 2449-2453, 1987.
11. Czerkinsky, C., Svennerholm, A. M., Quiding, M., Jonsson, R. & Holmgren, J.: Antibody-producing cells in peripheral blood and salivary glands after oral cholera vaccination of humans. Infect. Immun. 59: 996-1001, 1991.
12. Czerkinsky, C. C., Nilsson, L. A., Nygren, H., Ouchterlony, O. & Tarkowski, A.: A solid-phase enzyme-linked immunospot (ELISPOT) assay for enumeration of specific antibody-secreting cells. J. Immunol. Methods 65: 109-121, 1983.
13. Czerkinsky, C. C., Tarkowski, A., Nilsson, L. A., Ouchterlony, O., Nygren, H. & Gretzer, C.: Reverse enzyme-linked immunospot assay (RELISPOT) for the detection of cells secreting immunoreactive substances. J. Immunol. Methods 72: 489-496, 1984.
14. Elghazali, G., Esposito, F. & Troye, B. M.: Comparison of the number of IL-4 and IFN-gamma secreting cells in response to the malaria vaccine candidate antigen Pf155/RESA in two groups of naturally primed individuals living in a malaria endemic area in Burkina Faso. Scand. J. Immunol. 42: 39-5, 1995.
15. elGhazali, G. E., Paulie, S., Andersson, G., Hansson, Y., Holmquist, G., Sun, J. B., Olsson, T., Ekre, H. P. & Troye, B. M.: Number of interleukin-4 and interferon-gamma-secreting human T cells reactive with tetanus toxoid and the mycobacterial antigen PPD or phytohemagglutinin: distinct response profiles depending on the type of antigen used for activation. Eur. J. Immunol. 23: 2740-2745, 1993.
16. Fievet, N., Chougnet, C., Dubois, B. & Deloron, P.: Quantification of antibody-secreting lymphocytes that react with Pf155/RESA from Plasmodium falciparum: an ELISPOT assay for field studies. Clin. Exp. Immunol. 91: 63-67, 1993.
17. Forrest, B. D.: Identification of an intestinal immune response using peripheral blood lymphocytes. Lancet 1: 81-83, 1988.
18. Forrest, B. D.: Indirect measurement of intestinal immune responses to an orally administered attenuated bacterial vaccine. Infect. Immun. 60: 2023-2029, 1992.
19. Gronowicz, E., Coutinho, A. & Melchers, F.: A plaque assay for all cells secreting Ig of given type or class. Eur. J. Immunol. 4: 181-188, 1976.
20. Herrington, D. A., Van de Verg, L., Formal, S. B., Hale, T. L., Tall, B. D., Cryz, S. J., Tramont, E. C. & Levine, M. M.: Studies in volunteers to evaluate candidate Shigella vaccines: further experience with a bivalent Salmonella typhi-Shigella sonnei vaccine and protection conferred by previous Shigella sonnei disease. Vaccine 8: 353-357, 1990.
21. Holmgren, J., Czerkinsky, C., Lycke, N. & Svennerholm, A. M., Mucosal immunity: implications for vaccine development. Immunobiology 184: 157-179, 1992.
22. Hone, D. M., Tacket, C. O., Harris, A. M., Kay, B., Losonsky, G. & Levine, M. M.: Evaluation in volunteers of a candidate live oral attenuated Salmonella typhi vector vaccine. J. Clin. Invest. 90: 412-420, 1992.
23. Hutchings, P. R., Cambridge, G., Tite, J. P., Meager, T. & Cooke, A.: The detection and enumeration of cytokine-secreting cells in mice and man and the clinical application of these assays. J. Immunol. Methods 120: 1-8, 1989.
24. Isolauri, E., Joensuu, J., Suomalainen, H., Luomala, M. & Vesikari, T.: Improved immunogenicity of oral DxRRV reassortant rotavirus vaccine by Lactobacillus casei GG. Vaccine 13: 310-312, 1995.
25. Jerne, N. K., Henry, C., Nordin, A. A., Fuji, H., Korosz, A. M. C. & Lefkovitz, I.: Plaque forming cells: methodontology and theory. Transplant. Rev. 18: 130-191, 1974.
26. Jokinen, I., Poikonen, K. & Arvilommi, H.: Synthesis of human immunoglobulins in vitro: Comparison of two assays of secreted immunoglobulin. J. Immunoassay 6: 1-9, 1985.
27. Kaila, M., Isolauri, E., Virtanen, E. & Arvilommi, H.: Preponderance of IgM from blood lymphocytes in response to infantile rotavirus gastroenteritis. Gut 33: 639-642, 1992.
28. Kantele, A.: Antibody-secreting cells in the evaluation of the immunogenicity of an oral vaccine. Vaccine 8: 321 326, 1990.
29. Kantele, A.: Peripheral blood antibody-secreting cells in the evaluation of the immune response to an oral vaccine. J. Biotechnol. 44: 217-224, 1996.
30. Kantele, A., Arvilommi, H. & Jokinen, I.: Specific immunoglobulin-secreting human blood cells after peroral vaccination against Salmonella typhi. J. Infect. Dis. 153: 1126-1131, 1986.
31. Kantele, A., Kantele, J. M., Arvilommi, H. & Mäkela, P. H.: Active immunity is seen as a reduction in the cell response to oral live vaccine. Vaccine 9: 428-431, 1991.
32. Kantele, A. & Mäkela, P. H.: Different profiles of the human immune response to primary and secondary immunization with an oral Salmonella typhi Ty21a vaccine. Vaccine 9: 423-427, 1991.
33. Kantele, A., Papunen, R., Virtanen, E., Mottonen, T., Rasanen, L., Ala, K. K., Mäkelä, P. H. & Arvilommi, H.: Antibody-secreting cells in acute urinary tract infection as indicators of local immune response. J. Infect. Dis. 169: 1023-1028, 1994.
34. Kantete, A. M., Takanen, R. & Arvilommi, H.: Immune response to acute diarrhea seen as circulating antibody-secreting cells. J. Infect. Dis. 158: 1011-1016, 1988.
35. Kantele, J. M., Arvilommi, H., Kontiainen, S., Salmi, M., Jalkanen, S., Savilahti, E., Westerholm, M. & Kantele, A.: Mucosally activated circulating human B cells in diarrhea express homing receptors directing them back to the gut. Gastroenterology 110: 1061-1067, 1996.
36. Karttunen, R., Karttunen, T., Ekre, H. P. & MacDonald, T. T.: Interferon gamma and interleukin 4 secreting cells in the gastric antrum in Helicobacter pylori positive and negative gastritis. Gut 36: 341-345, 1995.
37. Kobayashi, K., Ueno, Y., Suzuki, H., Miura, M., Nagatomi, R., Ishii, M. & Toyota, T.: Anti-idiotypic antibody production in hepatitis B vaccine recipients. J. Gastroenterol. 29: 740-744, 1994.
38. Korhonen, J., Kantele, A., Qvarnberg, Y., Jyväkorpi, M. & Arvilommi, H.: Antibody secreting cells in acute maxillary sinusitis. Allergologie 12: 303-304, 1989.
39. Kotloff, K. L., Herrington, D. A., Hale, T. L., Newland, J. W., Van, D. V. L., Cogan, J. P., Snoy, P. J., Sadoff, J. C., Formal, S. B. & Levine, M. M.: Safety, immunogenicity, and efficacy in monkeys and humans of invasive Escherichia coli K-12 hybrid vaccine candidates expressing Shigella flexneri 2a somatic antigen. Infect Immun. 60: 2218-2224, 1992.
40. Lee, F. K., Nahmias, A. J., Lowery, S., Nesheim, S., Reef, S., Thompson, S., Oleske, J., Vahlne, A. & Czerkinsky, C.: ELISPOT: a new approach to studying the dynamics of virus-immune system interaction for diagnosis and monitoring of HIV infection. Aids Res. Hum. Retroviruses 5: 517-523, 1989.
41. Lewis, D. J., Novotny, P., Dougan, G. & Griffin, G. E.: The early cellular and humoral immune response to primary and booster oral immunization with cholera toxin B subunit. Eur. J. Immunol. 21: 2087-2094, 1991.
42. Lue, C., Tarkowski, A. & Mestecky, J.: Systemic immunization with pneumococcal polysaccharide vaccine induces a predominant IgA2 response of peripheral blood lymphocytes and increases of both serum and secretory anti-pneumococcal antibodies. J. Immunol. 140: 3793-3800, 1988.
43. Lycke, N., Hellstrom, U. & Holmgren, J.: Circulating cholera antitoxin memory cells in the blood one year after oral cholera vaccination in humans. Scand. J. Immunol. 26: 207-211, 1987.
44. Lycke, N., Lindholm, L. & Holmgren, J.: Cholera antibody production in vitro by peripheral blood lymphocytes following oral immunization of humans and mice. Clin. Exp. Immunol. 62: 39-47, 1985.
45. Merville, P., Pouteil, N. C., Wijdenes, J., Potaux, L., Touraine, J. L. & Banchereau, J.: Detection of single cells secreting IFN-gamma, IL-6, and IL-10 in irreversibly rejected human kidney allografts, and their modulation by IL-2 and IL-4. Transplantation 55: 639-646, 1993.
46. Mestecky, J.: The common mucosal immune system and current strategies for induction of immune responses in external secretions. J. Clin. Immunol. 7: 265-276, 1987.
47. Mire-Sluis, A. R., Gaines-Das, R. & Thorpe, R.: Immunoassays for detecting cytokines: What are they really measuring? J. Immunol. Methods 186: 157-160, 1995.
48. Munoz, C., Baqar, S., van de Verg, L., Thupari, J., Goldblum, S., Olson, J. G., Taylor, D. N. Heresi, G. P. & Murphy, J. R.: Characteristics of Shigella sonnei infection of volunteers: signs, symptoms, immune responses, changes in selected cytokines and acute-phase substances. Am. J. Trop. Med. Hyg. 53: 47-54, 1995.
49. Murphy, J. R.: Diarrhoeal disease: current concepts and future challenges. Rapid detection of enteric infections by measurement of enteric pathogen-specific antibody secreting cells in peripheral blood. Trans. R. Soc. Trop. Med. Hyg. 3: 27-30, 1993.
50. Mäkelä, M., Nikkari, S., Meurman, O., Laine, M. & Arvilommi, H.: Virus-specific, antibody-secreting cells during upper respiratory infections. J. Med. Virol. 47: 416-420, 1995.
51. Nesheim, S., Lee, F., Sawyer, M., Jones, D., Lindsay, M., Slade, B., Shaffer, N., Holmes, R., Ashby, R., Grimes, V. et al.: Diagnosis of human immunodeficiency virus infection by enzyme-linked immunospot assays in a prospectively followed cohort of infants of human immunodeficiency virus-seropositive women. Pediatr. Infect. Dis. J. 11: 635-639, 1992.
52. Nieminen, T., Virolainen, A., Käyhty, H., Jero, J., Karma, P., Leinonen, M. & Eskola, J.: Antibody-secreting cells and their relation to humoral antibodies in serum and in nasopharyngeal aspirates in children with pneumococcal acute otitis media. J. Infect. Dis. 173: 136-141, 1996.
53. Nordstrom, I. & Ferrua, B.: Reverse ELISPOT assay for clonal analysis of cytokine production. II. Enumeration of interleukin-1-secreting cells by amplified (avidin-biotin anti-peroxidase) assay. J. Immunol. Methods 150: 199-206, 1992.
54. Ogawa, T., Kono, Y., McGhee, M. L., McGhee, J. R., Roberts, J. E., Hamada, S. & Kiyono, H.: Porphyromonas gingivalis-specific serum IgG and IgA antibodies originate from immunoglobulin-secreting cells in inflamed gingiva. Clin. Exp. Immunol. 83: 237-244, 1991.
55. Ogawa, T., McGhee, M. L., Moldoveanu, Z., Hamada, S., Mestecky, J., McGhee, J. R. & Kiyono, H.: Bacteroides-specific IgG and IgA subclass antibody-secreting cells isolated from chronically inflamed gingival tissues. Clin. Exp. Immunol. 76: 103-110, 1989.
56. Orr, N., Robin, G., Lowell, G. & Cohen, D.: Presence of specific immunoglobulin A-secreting cells in peripheral blood after natural infection with Shigella sonnei. J. Clin. Microbiol. 30: 2165-2168, 1992.
57. Quiding, J. M., Lakew, M., Nordstrom, I., Banchereau, J., Butcher, E., Holmgren, J. & Czerkinsky, C.: Human circulating specific antibody-forming cells after systemic and mucosal immunizations: differential homing commitments and cell surface differentiation markers. Eur. J. Immunol. 25: 322-327, 1995.
58. Quiding, M., Nordstrom, I., Kilander, A., Andersson, G., Hanson, L. A., Holmgren, J. & Czerkinsky, C.: Intestinal immune responses in humans. Oral cholera vaccination induces strong intestinal antibody responses and interferon-gamma production and evokes local immunological memory. J. Clin. Invest. 88: 143-148, 1991.
59. Schwartz, D. H., Cosentino, L. M., Shirai, A., Conover, J., Daniel, S. & Klinman, D. M.: Lack of correlation between the number of circulating B cells and the concentration of serum antibodies reactive with the HIV-1 envelope glycoprotein. J. Acquir. Immune Defic. Syndr. 7: 447-453, 1994.
60. Sedgwick, J. D. & Czerkinsky, C.: Detection of cell-surface molecules, secreted products of single cells and cellular proliferation by enzyme immunoassay. J. Immunol. Methods 150: 159-175, 1992.
61. Sedgwick, J. D. & Holt, P. G.: A solid-phase immunoenzymatic technique for the enumeration of specific antibody-secreting cells. J. Immunol. Methods 48: 301-309, 1983.
62. Stevens, R. H., Macy, E., Morrow, C. & Saxon, A.: Characterization of a circulating subpopulation of spontaneous antitetanus toxoid antibody producing B cells following in vivo booster immunization. J. Immunol. 122: 2498-2504, 1979.
63. Sugiyama, T., Yabana, T. & Yachi, A.: Mucosal immune response to Helicobacter pylori and cytotoxic mechanism. Scand. J. Gastroenterol. (Suppl. 208): 30-32, 1995.
64. Surcel, H. M., Troye, B. M., Paulie, S., Andersson, G., Moreno, C., Pasvol, G. & Ivanyi, J.: Th1/ Th2 profiles in tuberculosis, based on the proliferation and cytokine response of blood lymphocytes to mycobacterial antigens. Immunology 81: 171-176, 1994.
65. Tacket, C. O., Reid, R. H., Boedeker, E. C. Losonsky, G., Nataro, J. P., Bhagat, H. & Edelman, R.: Enterai immunization and challenge of volunteers given enterotoxigenic E. coli CFA/II encapsulated in biodegradable microspheres. Vaccine 12: 1270-1274, 1994.
66. Tarkowski, A., Lue, C., Moldoveanu, Z., Kiyono, H., McGhee, J. R. & Mestecky, J.: Immunization of humans with polysaccharide vaccines induces systemic, predominantly polymeric IgA2-subclass antibody responses. J. Immunol. 144: 3770-3778, 1990.
67. Taylor, D. N., Phillip, D. F., Zapor, M., Trofa, A., Van de Verg, L., Hartman, A., Bendiuk, N., Newland, J. W., Formal, S. B., Sadoff, J. C. et al.: Outpatient studies of the safety and immunogenicity of an auxotrophic Escherichia coli K-12-Shigella flexneri 2a hybrid vaccine candidate, EcSf2a-2. Vaccine 12: 565-568, 1994.
68. Van de Verg, L., Herrington, D. A., Murphy, J. R., Wasserman, S. S., Formal, S. B. & Levine, M. M.: Specific immunoglobulin A-secreting cells in peripheral blood of humans following oral immunization with a bivalent Salmonella typhi-Shigella sonnei vaccine or infection by pathogenic S. sonnei. Infect. Immun. 58: 2002-2204, 1990.
69. Wenneras, C., Svennerholm, A. M., Ahren, C. & Czerkinsky, C.: Antibody-secreting cells in human peripheral blood after oral immunization with an inactivated enterotoxigenic Escherichia coli vaccine. Infect. Immun. 60: 2605-2611, 1992.
70. Yarchoan, R., Murphy, B. R., Strober, W., Clements, M. L. & Nelson, D.: In vitro production of anti-influenza virus antibody after intranasal inoculation with cold-adapted influenza virus. J. Immunol. 127: 1958-1963, 1981.